0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Treatment of Visceral Leishmaniasis-Reply

LUDO M. MAHIEU, MD; KAREL J. VAN ACKER, MD
Am J Dis Child. 1992;146(9):1021. doi:10.1001/archpedi.1992.02160210023011.
Text Size: A A A
Published online

In Reply.—We thank Özsoylu for his comments. The purpose of our letter was not to discuss the different aspects of leishmaniasis in full but to bring the possible loopholes in its diagnosis to the attention of those who are less familiar with this disease but who will probably be increasingly confronted with it. The references that we selected were mainly intended to illustrate the danger of unrecognized leishmaniasis. For the same reason we did not discuss in detail the therapeutic aspects.

When treating our patient we followed the recommendations of Brysecon,1 which were based on a large survey of the literature. Even with splenomegaly persisting for some time, treatment in our patient can be considered successful since no relapses have occurred after more than 20 months. Judging from his results, Özsoylu's treatment regimen is an obvious alternative. It appears that both treatment with lower doses of pentavalent antimony for a

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();